Zhu Rong-Rong, Xu Qi-Rong, Liu Zhong-Yong, Zhou Xue-Liang
Clinical School of Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Department of Cardiology, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, China.
J Thorac Dis. 2025 Aug 31;17(8):6127-6150. doi: 10.21037/jtd-2025-1462. Epub 2025 Aug 28.
Pathological cardiac hypertrophy leading to ventricular remodeling poses a significant threat to human health. Circular RNAs (circRNAs) play a potential role in the dysregulation of cardiac hypertrophy, and recent evidence highlights their translational ability in various diseases. However, it is not clear whether circRNAs play a protein-coding role in myocardial hypertrophy and ventricular remodeling. This study aimed to investigate the role of circRNA derived from the fat mass and obesity-associated () gene (circFTO), a translatable circRNA, and the circFTO-encoded a 36 amino acid protein (FTO-36aa) in the pathogenesis of myocardial hypertrophy.
A transverse aortic constriction (TAC)-induced hypertrophy mouse model was established. The heart function of the C57BL/6 mice was evaluated. Myocardial structure injury and fibrosis were analyzed by hematoxylin and eosin (H&E) staining and Masson staining. CircRNA microarray assays were used to screen the dysregulated circRNAs. The recombinant adenovirus-associated virus (AAV) was constructed to overexpress or knockdown FTO protein or circFTO. Mass spectrometry analyses, dual-luciferase reporter assays, and polysome profiling analyses were performed to detect the FTO-36aa.
The study identified dysregulated circRNAs in sham and TAC models, and found that an upregulated circRNA, circFTO, is generated from the back-splicing of FTO exon 5 and exon 7. The silencing of circFTO by AAV significantly weakened the TAC-induced hypertrophy phenotype. The study also identified a novel protein, FTO-36aa, coded by circFTO, that caused the pro-hypertrophy effect of circFTO. FTO-36aa promoted the ubiquitination-mediated protein degradation of FTO, which suppressed the demethylation of RNA, elevating the global N6-methyladenosine (mA) methylation. Further, the mA reader, IGF2BP2, recognized the circFTO/FTO-36aa elevated mA methylation and increased the messenger RNA (mRNA) stabilities of the mA methylated hypertrophic genes.
Overall, this study shed light on the functional importance of alternative splicing-generated circFTO and its coded FTO-36aa during myocardial hypertrophy. The findings provide fundamental insights into the mechanisms of mA methylation regulation in hypertrophic cardiomyocytes.
病理性心脏肥大导致心室重构,对人类健康构成重大威胁。环状RNA(circRNA)在心脏肥大的失调中发挥潜在作用,最近的证据凸显了它们在各种疾病中的翻译能力。然而,尚不清楚circRNA在心肌肥大和心室重构中是否发挥蛋白质编码作用。本研究旨在探讨源自脂肪量和肥胖相关(FTO)基因的circRNA(circFTO),一种可翻译的circRNA,以及circFTO编码的一种36个氨基酸的蛋白质(FTO-36aa)在心肌肥大发病机制中的作用。
建立横向主动脉缩窄(TAC)诱导的肥大小鼠模型。评估C57BL/6小鼠的心脏功能。通过苏木精和伊红(H&E)染色及Masson染色分析心肌结构损伤和纤维化。使用circRNA微阵列分析筛选失调的circRNA。构建重组腺相关病毒(AAV)以过表达或敲低FTO蛋白或circFTO。进行质谱分析、双荧光素酶报告基因分析和多核糖体谱分析以检测FTO-36aa。
该研究在假手术和TAC模型中鉴定出失调的circRNA,并发现一种上调的circRNA,即circFTO,由FTO外显子5和外显子7的反向剪接产生。AAV介导的circFTO沉默显著减弱了TAC诱导的肥大表型。该研究还鉴定出一种由circFTO编码的新型蛋白质FTO-36aa,它导致了circFTO的促肥大作用。FTO-36aa促进了泛素化介导的FTO蛋白降解,从而抑制了RNA的去甲基化,提高了整体N6-甲基腺苷(m6A)甲基化水平。此外,m6A阅读器IGF2BP2识别circFTO/FTO-36aa升高的m6A甲基化,并增加了m6A甲基化的肥大相关基因的信使核糖核酸(mRNA)稳定性。
总体而言,本研究揭示了选择性剪接产生的circFTO及其编码的FTO-36aa在心肌肥大过程中的功能重要性。这些发现为肥厚型心肌细胞中m6A甲基化调控机制提供了基本见解。